Disclaimer: This site has been first put up 15 years ago. Since then I would probably do a couple things differently, but because I've noticed this site had been linked from news outlets, PhD theses and peer rewieved papers and because I really hate the concept of "digital dark age" I've decided to put it back up. There's no chance it can produce any harm now.
| Identifier: | 05MADRID1710 |
|---|---|
| Wikileaks: | View 05MADRID1710 at Wikileaks.org |
| Origin: | Embassy Madrid |
| Created: | 2005-05-04 15:56:00 |
| Classification: | UNCLASSIFIED |
| Tags: | TBIO OSCI KSCA SP |
| Redacted: | This cable was not redacted by Wikileaks. |
This record is a partial extract of the original cable. The full text of the original cable is not available. 041556Z May 05
UNCLAS MADRID 001710 SIPDIS STATE PLEASE PASS TO DHHS/NIH/FIC: SONJA MADERA E.O. 12958: N/A TAGS: TBIO, OSCI, KSCA, SP SUBJECT: REQUEST FOR ASSESSMENT OF FOREIGN POLICY IMPLICATIONS OF PROPOSED RESEARCH PROJECT NO. 1 U01 AI61242- 01 DIRECTLY TO FOREIGN INSTITUTIONS REF: STATE 074308 Per reftel request, Embassy contacted "ROVI Laboratorios Farmaceuticos." An assistant to principal investigator Juan Lopez-Belmonte informed us that ROVI is part of a three- party consortium which also includes an Austrian and German companies. The project is currently in the phase of scientific research development and ROVI's eventual role would be to package the product. However, our interlocutor stressed that ROVI has not yet signed a contract and thus its eventual participation in the consortium is not yet assured. MANZANARES
Latest source of this page is cablebrowser-2, released 2011-10-04